Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy?

Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? Clin Cancer Res. 2013 Mar 01; 19(5):958-60.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.